Agilent Technologies, Inc. (A)

NYSE: A · Real-Time Price · USD
118.62
+0.98 (0.83%)
At close: Jun 25, 2025, 4:00 PM
118.62
0.00 (0.00%)
After-hours: Jun 25, 2025, 4:20 PM EDT
0.83%
Market Cap 33.70B
Revenue (ttm) 6.63B
Net Income (ttm) 1.17B
Shares Out 284.06M
EPS (ttm) 4.06
PE Ratio 29.21
Forward PE 20.39
Dividend $0.99 (0.84%)
Ex-Dividend Date Jul 1, 2025
Volume 1,685,399
Open 117.11
Previous Close 117.64
Day's Range 116.97 - 119.78
52-Week Range 96.43 - 153.84
Beta 1.23
Analysts Buy
Price Target 139.67 (+17.75%)
Earnings Date Aug 20, 2025

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]

Sector Healthcare
IPO Date Nov 18, 1999
Employees 17,900
Stock Exchange NYSE
Ticker Symbol A
Full Company Profile

Financial Performance

In 2024, Agilent Technologies's revenue was $6.51 billion, a decrease of -4.73% compared to the previous year's $6.83 billion. Earnings were $1.29 billion, an increase of 3.95%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for A stock is "Buy." The 12-month stock price forecast is $139.67, which is an increase of 17.75% from the latest price.

Price Target
$139.67
(17.75% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Agilent to Showcase New Products and Innovations at HPLC 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spec...

13 days ago - Business Wire

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)

Agilent Technologies, Inc. (NYSE:A) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior ...

21 days ago - Seeking Alpha

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript

Agilent Technologies, Inc. (NYSE:A) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SV...

27 days ago - Seeking Alpha

Life sciences firm Agilent beats quarterly estimates on instrument demand

Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up ...

4 weeks ago - Reuters

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.67 billion for the second quarter ended April 30, 2025, representing growth of 6.0% reported and ...

4 weeks ago - Business Wire

Agilent Names August Specht as Chief Technology Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company's Chief Technology Officer. Specht, previously vice president...

4 weeks ago - Business Wire

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest enhancements to the Agilent 8850 Gas Chromatograph (GC), including compatibility with single and tr...

4 weeks ago - Business Wire

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of its latest innovation in liquid chromatography (LC)-mass detection: the Agilent InfinityLab Pro ...

4 weeks ago - Business Wire

Agilent Announces Cash Dividend of 24.8 Cents per Share

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on July 23,...

5 weeks ago - Business Wire

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been...

5 weeks ago - Business Wire

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Infinity III LC Series — the company's latest liquid chromatography (LC) instruments — are the first ...

5 weeks ago - Business Wire

Agilent to Participate in Jefferies Global Healthcare Conference

SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at the Jefferies ...

5 weeks ago - Business Wire

Scale Has Its Advantages: 3 A-Rated REIT Monopolies

Scale is a critical competitive advantage for companies, enabling them to expand, attract capital, and achieve strong market positions, as seen with Realty Income, Prologis, and Public Storage. Realty...

Other symbols: AMTDLREXRMAAOPLDPSA
6 weeks ago - Seeking Alpha

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well system designed to expand real-time ...

7 weeks ago - Business Wire

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying opportunity. The shares are cumulative, redee...

Other symbols: CIO
2 months ago - Seeking Alpha

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

LEWISVILLE, Ark., April 24, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a Joint Venture (“JV”) between Standard Lithium Ltd.

2 months ago - GlobeNewsWire

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 i...

2 months ago - Business Wire

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR certification for the use as a Compan...

2 months ago - Business Wire

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-t...

Other symbols: CSXJBHTNKEOMCPPGTGT
2 months ago - Seeking Alpha

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T ther...

3 months ago - Business Wire

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE N...

3 months ago - Business Wire

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, w...

3 months ago - Business Wire

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski...

3 months ago - Business Wire

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1,...

3 months ago - Business Wire

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Agilent Technologies, Inc. (NYSE:A) TD Cowen 45th Annual Healthcare Conference Call March 4, 2025 9:50 AM ET Company Participants Padraig McDonnell - Chief Executive Officer Bob McMahon - Chief Finan...

4 months ago - Seeking Alpha